Pulmonary complications associated with combination chemotherapy programs containing bleomycin.

The American journal of medicine ·Vol. 74 ·No. 4 ·1983-04-00 ·Pages 557-63

Bauer KA, Skarin AT, Balikian JP, Garnick MB, Rosenthal DS, Canellos GP

Abstract

暂无摘要

MeSH Terms

Antineoplastic Combined Chemotherapy Protocols Bleomycin/adverse effects Cisplatin/adverse effects Cyclophosphamide/adverse effects Dexamethasone/adverse effects Doxorubicin/adverse effects Drug Interactions Drug Therapy, Combination Female Humans Leucovorin/adverse effects Lung Diseases/chemically induced Lymphoma/drug therapy Male Methotrexate/adverse effects Pulmonary Fibrosis/chemically induced Respiratory Distress Syndrome/chemically induced Testicular Neoplasms/drug therapy Vinblastine/adverse effects Vincristine/adverse effects

Chemicals

Bleomycin Vincristine Vinblastine Dexamethasone Doxorubicin Cyclophosphamide Cisplatin Leucovorin Methotrexate

Authors & Affiliations

6 authors, click to expand affiliations / ORCID

Bauer K A

Skarin A T

Balikian J P

Garnick M B

Rosenthal D S

Canellos G P

Supplementary Concepts

M-BACOD protocol (Protocol) PVB protocol (Protocol)

Article Info

Journal

The American journal of medicine

Abbr.

Am J Med

ISSN

0002-9343

DOI

10.1016/0002-9343(83)91009-4

Published

1983-04-00

Pages

557-63

Language

English

Region

United States

NLM ID

0267200

Subset

External Links

PubMed source DOI: 10.1016/0002-9343(83)91009-4 View journal details

Analysis Services

Pulmonary complications associated with combination chemotherapy programs containing bleomycin.

Contact

WeChat Official Account